A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

T.S. Waddell, I. Chau, Y. Barbachano, D.G. de Castro, A. Wotherspoon, C. Saffery, G.W. Middleton, J. Wadsley, D.R. Ferry, W. Mansoor, T.D.L. Crosby, F.Y. Coxon, D. Smith, J.S. Waters, T. Iveson, S. Falk, S. Slater, A.F.C. Okines, D. Cunningham

Research output: Contribution to conference › Other

Original languageEnglish
Publication statusPublished - 20 Jun 2012

Cite this

Waddell, T.S. ; Chau, I. ; Barbachano, Y. ; de Castro, D.G. ; Wotherspoon, A. ; Saffery, C. ; Middleton, G.W. ; Wadsley, J. ; Ferry, D.R. ; Mansoor, W. ; Crosby, T.D.L. ; Coxon, F.Y. ; Smith, D. ; Waters, J.S. ; Iveson, T. ; Falk, S. ; Slater, S. ; Okines, A.F.C. ; Cunningham, D. / A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3).
@conference{af61abb156724f40967057f31db49475,
title = "A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)",
author = "T.S. Waddell and I. Chau and Y. Barbachano and {de Castro}, D.G. and A. Wotherspoon and C. Saffery and G.W. Middleton and J. Wadsley and D.R. Ferry and W. Mansoor and T.D.L. Crosby and F.Y. Coxon and D. Smith and J.S. Waters and T. Iveson and S. Falk and S. Slater and A.F.C. Okines and D. Cunningham",
year = "2012",
month = "6",
day = "20",
language = "English",

}

Waddell, TS, Chau, I, Barbachano, Y, de Castro, DG, Wotherspoon, A, Saffery, C, Middleton, GW, Wadsley, J, Ferry, DR, Mansoor, W, Crosby, TDL, Coxon, FY, Smith, D, Waters, JS, Iveson, T, Falk, S, Slater, S, Okines, AFC & Cunningham, D 2012, 'A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)'.

A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3). / Waddell, T.S.; Chau, I.; Barbachano, Y.; de Castro, D.G.; Wotherspoon, A.; Saffery, C.; Middleton, G.W.; Wadsley, J.; Ferry, D.R.; Mansoor, W.; Crosby, T.D.L.; Coxon, F.Y.; Smith, D.; Waters, J.S.; Iveson, T.; Falk, S.; Slater, S.; Okines, A.F.C.; Cunningham, D.

2012.

Research output: Contribution to conference › Other

TY - CONF

T1 - A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

AU - Waddell, T.S.

AU - Chau, I.

AU - Barbachano, Y.

AU - de Castro, D.G.

AU - Wotherspoon, A.

AU - Saffery, C.

AU - Middleton, G.W.

AU - Wadsley, J.

AU - Ferry, D.R.

AU - Mansoor, W.

AU - Crosby, T.D.L.

AU - Coxon, F.Y.

AU - Smith, D.

AU - Waters, J.S.

AU - Iveson, T.

AU - Falk, S.

AU - Slater, S.

AU - Okines, A.F.C.

AU - Cunningham, D.

PY - 2012/6/20

Y1 - 2012/6/20

M3 - Other

ER -

Waddell TS, Chau I, Barbachano Y, de Castro DG, Wotherspoon A, Saffery C et al. A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3). 2012.

Access to Document